Physician Burnout Eroding Sense of Calling

This article originally appeared here.
Share this content:
Physician Burnout Eroding Sense of Calling
Physician Burnout Eroding Sense of Calling

TUESDAY, Feb. 28, 2017 (HealthDay News) -- For physicians across specialties, burnout is associated with reduced odds of a sense of calling, according to a study published online Feb. 8 in the Mayo Clinic Proceedings.

Andrew J. Jager, from the American Medical Association in Chicago, and colleagues surveyed U.S. physicians across all specialties to examine the correlation between degree of burnout and physicians' sense of calling. A single-item measure was used to assess professional burnout, while six validated true-false items were used to evaluate sense of calling, defined as committing one's life to personally meaningful work that serves a prosocial purpose.

The researchers found that 28.5 percent of the 2,263 physicians who completed surveys reported experiencing some degree of burnout. Compared with physicians who reported no burnout, those who were completely burned out had lower odds of finding their work rewarding, seeing their work as one of the most important things in their lives, or thinking that their work makes the world a better place (odds ratios, 0.05, 0.38, and 0.38, respectively) compared with physicians reporting no burnout symptoms. Burnout also correlated with reduced odds of enjoying talking about their work to others, choosing their work life again, or continuing their work without being paid if they were financially stable (odds ratios, 0.23, 0.11, and 0.3, respectively).

"Physicians who experience more burnout are less likely to identify with medicine as a calling," the authors write. "Erosion of the sense that medicine is a calling may have adverse consequences for physicians as well as those for whom they care."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »